| Charles Pound, MD | |
|
2500 North State Street, Jackson, MS 39216-4500 | |
| (601) 925-6805 | |
| (601) 926-4978 |
| Full Name | Charles Pound |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 31 Years |
| Location | 2500 North State Street, Jackson, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740381045 | NPI | - | NPPES |
| 157214 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 18608 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Mississippi Med Center | Jackson, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| State Of Mississippi - University Of Mississippi Medical Center | 1850293036 | 804 |
News Archive
QRxPharma announced today successful completion of two Phase 1 studies in healthy volunteers for MoxDuo CR, a controlled-release Dual-Opioid utilising a 3:2 ratio of morphine and oxycodone.
Cancer metastasis, which is the dissemination of tumor cells into distant organs, is the leading cause of mortality in cancer patients. To undergo metastasis, cells must leave the primary tumor, circulate into the blood, colonize distant organs, and form distant metastasis.
Environmental cleanup experts gathered at NJIT this week for an all-day public forum on a $1.7 billion proposal by the U.S. Environmental Protection Agency (EPA) to dredge toxic sediment from an eight-mile stretch of the lower Passaic River.
For the first time, researchers at Seattle Cancer Care Alliance have demonstrated the feasibility of using serial positron emission tomography (PET) scans, using a special estrogen-containing isotope, to confirm the relative effectiveness of estrogen-blocking and estrogen-depleting therapy in patients with metastatic breast cancer.
MSD, known as Merck in the United States and Canada, announced today that final results from the two pivotal Phase III studies of VICTRELIS, its investigational oral hepatitis C protease inhibitor, will be published in the March 31st edition of The New England Journal of Medicine.
› Verified 2 days ago
| Entity Name | Mississippi State Hospital At Whitfield |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336224179 PECOS PAC ID: 5294727533 Enrollment ID: O20040330000795 |
News Archive
QRxPharma announced today successful completion of two Phase 1 studies in healthy volunteers for MoxDuo CR, a controlled-release Dual-Opioid utilising a 3:2 ratio of morphine and oxycodone.
Cancer metastasis, which is the dissemination of tumor cells into distant organs, is the leading cause of mortality in cancer patients. To undergo metastasis, cells must leave the primary tumor, circulate into the blood, colonize distant organs, and form distant metastasis.
Environmental cleanup experts gathered at NJIT this week for an all-day public forum on a $1.7 billion proposal by the U.S. Environmental Protection Agency (EPA) to dredge toxic sediment from an eight-mile stretch of the lower Passaic River.
For the first time, researchers at Seattle Cancer Care Alliance have demonstrated the feasibility of using serial positron emission tomography (PET) scans, using a special estrogen-containing isotope, to confirm the relative effectiveness of estrogen-blocking and estrogen-depleting therapy in patients with metastatic breast cancer.
MSD, known as Merck in the United States and Canada, announced today that final results from the two pivotal Phase III studies of VICTRELIS, its investigational oral hepatitis C protease inhibitor, will be published in the March 31st edition of The New England Journal of Medicine.
› Verified 2 days ago
| Entity Name | State Of Mississippi - University Of Mississippi Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154317527 PECOS PAC ID: 1850293036 Enrollment ID: O20090414000575 |
News Archive
QRxPharma announced today successful completion of two Phase 1 studies in healthy volunteers for MoxDuo CR, a controlled-release Dual-Opioid utilising a 3:2 ratio of morphine and oxycodone.
Cancer metastasis, which is the dissemination of tumor cells into distant organs, is the leading cause of mortality in cancer patients. To undergo metastasis, cells must leave the primary tumor, circulate into the blood, colonize distant organs, and form distant metastasis.
Environmental cleanup experts gathered at NJIT this week for an all-day public forum on a $1.7 billion proposal by the U.S. Environmental Protection Agency (EPA) to dredge toxic sediment from an eight-mile stretch of the lower Passaic River.
For the first time, researchers at Seattle Cancer Care Alliance have demonstrated the feasibility of using serial positron emission tomography (PET) scans, using a special estrogen-containing isotope, to confirm the relative effectiveness of estrogen-blocking and estrogen-depleting therapy in patients with metastatic breast cancer.
MSD, known as Merck in the United States and Canada, announced today that final results from the two pivotal Phase III studies of VICTRELIS, its investigational oral hepatitis C protease inhibitor, will be published in the March 31st edition of The New England Journal of Medicine.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Charles Pound, MD Po Box 24146, Jackson, MS 39225-4146 Ph: (601) 925-6805 | Charles Pound, MD 2500 North State Street, Jackson, MS 39216-4500 Ph: (601) 925-6805 |
News Archive
QRxPharma announced today successful completion of two Phase 1 studies in healthy volunteers for MoxDuo CR, a controlled-release Dual-Opioid utilising a 3:2 ratio of morphine and oxycodone.
Cancer metastasis, which is the dissemination of tumor cells into distant organs, is the leading cause of mortality in cancer patients. To undergo metastasis, cells must leave the primary tumor, circulate into the blood, colonize distant organs, and form distant metastasis.
Environmental cleanup experts gathered at NJIT this week for an all-day public forum on a $1.7 billion proposal by the U.S. Environmental Protection Agency (EPA) to dredge toxic sediment from an eight-mile stretch of the lower Passaic River.
For the first time, researchers at Seattle Cancer Care Alliance have demonstrated the feasibility of using serial positron emission tomography (PET) scans, using a special estrogen-containing isotope, to confirm the relative effectiveness of estrogen-blocking and estrogen-depleting therapy in patients with metastatic breast cancer.
MSD, known as Merck in the United States and Canada, announced today that final results from the two pivotal Phase III studies of VICTRELIS, its investigational oral hepatitis C protease inhibitor, will be published in the March 31st edition of The New England Journal of Medicine.
› Verified 2 days ago
Robert Tramel, Urology Medicare: Medicare Enrolled Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 769-798-4747 | |
Dr. Mark Runnels, Urology Medicare: Accepting Medicare Assignments Practice Location: 1421 N State St, Ste 403, Jackson, MS 39202 Phone: 601-353-9900 Fax: 601-353-3654 | |
Dr. Michael Tyler Wood, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-5101 | |
Dr. Kieran Hynes, MD Urology Medicare: Medicare Enrolled Practice Location: 501 Marshall St Ste 301, Jackson, MS 39202 Phone: 601-353-9900 | |
Ronald D Davis, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 971 Lakeland Dr, Suite 360, Jackson, MS 39216 Phone: 601-200-4370 Fax: 601-200-4375 | |
Joe R. Ross, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1421 N State St, Suite 403, Jackson, MS 39202 Phone: 601-353-9900 Fax: 601-353-3654 | |
Deep Asit Gandhi, MD Urology Medicare: Medicare Enrolled Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-1000 |